Bioten is a company established in August 2011 for the purpose of commercialization through technology transfer
and joint research on “viral infection treatment” by KRIBB(Korea Research Institute of Bioscience and Biotechnology).
Through joint research with the KRIBB, a government-funded research institute, the absorption rate and persistence
of curcumin in the body were improved by about 400 to 1,000 times, and Tencumin S Plus and G Plus were developed